Overview

Minimally Invasive Sensing of Beta-lactam Antibiotics

Status:
Completed
Trial end date:
2018-08-10
Target enrollment:
Participant gender:
Summary
This study is an in-house feasibility study of a microneedle biosensor developed within Imperial College London.
Phase:
Phase 1
Details
Lead Sponsor:
Imperial College London
Treatments:
Anti-Bacterial Agents
beta-Lactams
Lactams
Penicillin V
Penicillins